These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1098 related articles for article (PubMed ID: 31941776)

  • 1. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
    Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Inhibitors of ZIKV Replication.
    Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germacrone inhibits early stages of influenza virus infection.
    Liao Q; Qian Z; Liu R; An L; Chen X
    Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide.
    Tilmanis D; van Baalen C; Oh DY; Rossignol JF; Hurt AC
    Antiviral Res; 2017 Nov; 147():142-148. PubMed ID: 28986103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolic acid, an immunomodulator, has potent and broad-spectrum in vitro antiviral activity against pandemic, seasonal and avian influenza viruses affecting humans.
    To KKW; Mok KY; Chan ASF; Cheung NN; Wang P; Lui YM; Chan JFW; Chen H; Chan KH; Kao RYT; Yuen KY
    J Gen Virol; 2016 Aug; 97(8):1807-1817. PubMed ID: 27259985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
    Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
    Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition effects of novel polyketide compound PPQ-B against influenza A virus replication by interfering with the cellular EGFR pathway.
    Wang M; Wang S; Wang W; Wang Y; Wang H; Zhu W
    Antiviral Res; 2017 Jul; 143():74-84. PubMed ID: 28414053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of hydroalcoholic extract from Eupatorium perfoliatum L. against the attachment of influenza A virus.
    Derksen A; Kühn J; Hafezi W; Sendker J; Ehrhardt C; Ludwig S; Hensel A
    J Ethnopharmacol; 2016 Jul; 188():144-52. PubMed ID: 27178637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a Novel Specific Inhibitor Targeting Influenza A Virus Nucleoprotein with Pleiotropic Inhibitory Effects on Various Steps of the Viral Life Cycle.
    Yang F; Pang B; Lai KK; Cheung NN; Dai J; Zhang W; Zhang J; Chan KH; Chen H; Sze KH; Zhang H; Hao Q; Yang D; Yuen KY; Kao RY
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33627391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of aprotinin on influenza A and B viruses in vitro and in vivo.
    Song EJ; Españo E; Shim SM; Nam JH; Kim J; Lee K; Park SK; Lee CK; Kim JK
    Sci Rep; 2021 May; 11(1):9427. PubMed ID: 33941825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activity of an aqueous extract derived from Aloe arborescens Mill. against a broad panel of viruses causing infections of the upper respiratory tract.
    Glatthaar-Saalmüller B; Fal AM; Schönknecht K; Conrad F; Sievers H; Saalmüller A
    Phytomedicine; 2015 Sep; 22(10):911-20. PubMed ID: 26321740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Fluorescent and Bioluminescent Bireporter Influenza A Virus To Evaluate Viral Infections.
    Nogales A; Ávila-Pérez G; Rangel-Moreno J; Chiem K; DeDiego ML; Martínez-Sobrido L
    J Virol; 2019 May; 93(10):. PubMed ID: 30867298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.
    Sleeman K; Mishin VP; Deyde VM; Furuta Y; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2517-24. PubMed ID: 20350949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses.
    Zhang J; Hu Y; Hau R; Musharrafieh R; Ma C; Zhou X; Chen Y; Wang J
    Eur J Pharm Sci; 2019 May; 133():86-94. PubMed ID: 30930289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Multitarget-Directed Ligands Against Influenza A Virus From Compound Yizhihao Through a Predictive System for Compound-Protein Interactions.
    Xu L; Jiang W; Jia H; Zheng L; Xing J; Liu A; Du G
    Front Cell Infect Microbiol; 2020; 10():16. PubMed ID: 32117796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.
    Hu Y; Zhang J; Musharrafieh RG; Ma C; Hau R; Wang J
    Antiviral Res; 2017 Sep; 145():103-113. PubMed ID: 28778830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
    Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
    Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway.
    Yan H; Wang H; Ma L; Ma X; Yin J; Wu S; Huang H; Li Y
    Virol J; 2018 May; 15(1):88. PubMed ID: 29783993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin.
    Vanderlinden E; Marchand A; Van Berwaer R; van Dam W; Arzel P; Klaassen H; Persoons L; Chaltin P; Naesens L
    Antiviral Res; 2021 Dec; 196():105208. PubMed ID: 34793841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses.
    Courtin N; Fotso AF; Fautrad P; Mas F; Alessi MC; Riteau B
    Antiviral Res; 2017 Jul; 143():252-261. PubMed ID: 28483551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.